Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation

[1]  J. Erjefält,et al.  Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? , 2006, Trends in pharmacological sciences.

[2]  K. Hirokawa,et al.  Prostaglandin D2 Plays an Essential Role in Chronic Allergic Inflammation of the Skin via CRTH2 Receptor1 , 2006, The Journal of Immunology.

[3]  R. Peebles,et al.  Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think. , 2006, The Journal of allergy and clinical immunology.

[4]  L. Pardo,et al.  On the Mechanism of Interaction of Potent Surmountable and Insurmountable Antagonists with the Prostaglandin D2 Receptor CRTH2 , 2006, Molecular Pharmacology.

[5]  Ashley A. Barnes,et al.  9α,11β‐PGF2 and its stereoisomer PGF2α are novel agonists of the chemoattractant receptor, CRTH2 , 2006 .

[6]  J. Erjefält,et al.  Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  Ashley A. Barnes,et al.  9alpha,11beta-PGF2 and its stereoisomer PGF2alpha are novel agonists of the chemoattractant receptor, CRTH2. , 2006, FEBS letters.

[8]  D. Metcalfe,et al.  5. IgE, mast cells, basophils, and eosinophils. , 2006, The Journal of allergy and clinical immunology.

[9]  K. Tsubota,et al.  Prostaglandin D2 Induces Chemotaxis in Eosinophils Via Its Receptor CRTH2 and Eosinophils May Cause Severe Ocular Inflammation in Patients With Allergic Conjunctivitis , 2005, Cornea.

[10]  M. Pruniaux,et al.  Cutting Edge: Chemoattractant Receptor-Homologous Molecule Expressed on TH2 Cells Plays a Restricting Role on IL-5 Production and Eosinophil Recruitment , 2005, The Journal of Immunology.

[11]  Q. Hamid,et al.  Effects of Prostaglandin D2, 15-Deoxy-Δ12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[12]  M. Rosenkilde,et al.  A Highly Conserved Glycine within Linker I and the Extreme C Terminus of G Protein α Subunits Interact Cooperatively in Switching G Protein-Coupled Receptor-to-Effector Specificity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[13]  S. Fleury,et al.  Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse 1 , 2005, The Journal of Immunology.

[14]  T. Lybrand,et al.  Structural Determinants of Arylacetic Acid Nonsteroidal Anti-Inflammatory Drugs Necessary for Binding and Activation of the Prostaglandin D2 Receptor CRTH2 , 2005, Molecular Pharmacology.

[15]  C. Ward,et al.  Airway wall remodelling: the influence of corticosteroids , 2005, Current opinion in allergy and clinical immunology.

[16]  Yusuke Suzuki,et al.  Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.

[17]  E. Kostenis,et al.  Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. , 2005, Journal of medicinal chemistry.

[18]  M. Triggiani,et al.  Mast cells and basophils: friends as well as foes in bronchial asthma? , 2005, Trends in immunology.

[19]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[20]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[21]  A. Tager,et al.  T-cell trafficking in asthma: lipid mediators grease the way , 2004, Nature Reviews Immunology.

[22]  R. Breyer,et al.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.

[23]  K. Matsushima,et al.  Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor‐homologous molecule expressed on Th2 cells/DP2 , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  G. Sturm,et al.  11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils* , 2004, Journal of Biological Chemistry.

[25]  F. Gantner,et al.  Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells Activation in Vivo Increases Blood Leukocyte Counts and Its Blockade Abrogates 13,14-Dihydro-15-keto-prostaglandin D2-Induced Eosinophilia in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[26]  M. Hatano,et al.  Prostaglandin D2 Reinforces Th2 Type Inflammatory Responses of Airways to Low-dose Antigen through Bronchial Expression of Macrophage-derived Chemokine , 2003, The Journal of experimental medicine.

[27]  A. Hartnell,et al.  Δ12-Prostaglandin J2, a Plasma Metabolite of Prostaglandin D2, Causes Eosinophil Mobilization from the Bone Marrow and Primes Eosinophils for Chemotaxis1 , 2003, The Journal of Immunology.

[28]  F. Gantner,et al.  An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in Vitro , 2003, Journal of Pharmacology and Experimental Therapeutics.

[29]  Takeshi Watanabe,et al.  The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice. , 2003, International immunopharmacology.

[30]  E. Scolnick,et al.  Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation. , 2003, Analytical biochemistry.

[31]  A. Hartnell,et al.  Causes Eosinophil Mobilization from the Bone Marrow and Primes Eosinophils for Chemotaxis , 2003 .

[32]  C. Page,et al.  Asthma -- a need for a rethink? , 2002, Trends in pharmacological sciences.

[33]  J. Morrow,et al.  Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. , 2002, American journal of respiratory and critical care medicine.

[34]  G. O'neill,et al.  Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. , 2001, The Journal of allergy and clinical immunology.

[35]  J. Erjefält,et al.  Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. , 2001, American journal of respiratory and critical care medicine.

[36]  M. Diamond,et al.  Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. , 2001, Blood.

[37]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[38]  S. Narumiya,et al.  Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.

[39]  D. Zeldin,et al.  Allergic lung responses are increased in prostaglandin H synthase-deficient mice. , 1999, The Journal of clinical investigation.

[40]  Takamizawa,et al.  Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM‐1, VCAM‐1 or ELAM‐1 expression by human vascular endothelial cells , 1998, Clinical and experimental immunology.

[41]  A. Konno,et al.  The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis. , 1998, Acta oto-laryngologica. Supplementum.

[42]  F. Sundler,et al.  The mouse trap. , 1997, Trends in pharmacological sciences.

[43]  S. Durham,et al.  IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. , 1997, The Journal of allergy and clinical immunology.

[44]  F. Sundler,et al.  Allergic Eosinophil-rich Inflammation Develops in Lungs and Airways of B Cell–deficient Mice , 1997, The Journal of experimental medicine.

[45]  A. Kataura,et al.  Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. , 1996, International archives of allergy and immunology.

[46]  N. Hara,et al.  BAY u3405, a thromboxane A2 antagonist, reduces bronchial hyperresponsiveness in asthmatics. , 1996, Chest.

[47]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.

[48]  H. Takeda,et al.  The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions. , 1995, Prostaglandins.

[49]  D. Underwood,et al.  Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig. , 1994, The Journal of pharmacology and experimental therapeutics.

[50]  D. Jones.  The eosinophil. , 1993, Journal of comparative pathology.

[51]  S. Johnston,et al.  The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. , 1992, British journal of clinical pharmacology.

[52]  L. Pease,et al.  Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family , 1989, The Journal of experimental medicine.

[53]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.